bpi pharmacy semaglutide FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Breaking GLP1 Update 🚨 BPI

Our physicians monitor your response carefully through regular follow-ups and sleep quality assessments to optimize sleep benefits while minimizing any adaptation effects

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that has generated questions about potential effects on sexual function

In practice, the best approach is often a personalized plan, and many people benefit from using both medications together rather than choosing one over the other

GLP-1 and GIP/GLP-1 receptor agonists are used to treat Type 2 diabetes, lower the risk of major cardiovascular and kidney-related events, and/or to help people manage their body weight, among other uses

While most insurers cover GLP-1s like Rybelsus for type 2 diabetes, its generally not covered if prescribed for an off-label use like weight loss

Oral glutathione supplements are widely used for antioxidant support and skin wellness